130 related articles for article (PubMed ID: 6201115)
21. Receptor-mediated endocytosis of tuftsin by macrophage cells.
Gottlieb P; Hazum E; Tzehoval E; Feldman M; Segal S; Fridkin M
Biochem Biophys Res Commun; 1984 Feb; 119(1):203-11. PubMed ID: 6322775
[TBL] [Abstract][Full Text] [Related]
22. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
[TBL] [Abstract][Full Text] [Related]
23. Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity.
Dagan S; Gottlieb P; Tzehoval E; Feldman M; Fridkin M; Yasumura K; Okamoto K; Yajima H
J Med Chem; 1986 Oct; 29(10):1961-8. PubMed ID: 3761314
[TBL] [Abstract][Full Text] [Related]
24. Receptor-mediated internalization of tuftsin.
Amoscato AA; Davies PJ; Babcock GF; Nishioka K
Ann N Y Acad Sci; 1983; 419():114-34. PubMed ID: 6324633
[No Abstract] [Full Text] [Related]
25. Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis. A two-signal progenitor restricted, tuftsin-like effect.
Moore RN; Osmand AP; Dunn JA; Joshi JG; Rouse BT
J Immunol; 1988 Oct; 141(8):2699-703. PubMed ID: 2459223
[TBL] [Abstract][Full Text] [Related]
26. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.
Fridkin M; Stabinsky Y; Zakuth V; Spirer Z
Biochim Biophys Acta; 1977 Jan; 496(1):203-11. PubMed ID: 576412
[TBL] [Abstract][Full Text] [Related]
27. Regulation of cyclic GMP levels by neurotensin in neuroblastoma clone N1E115.
Amar S; Mazella J; Checler F; Kitabgi P; Vincent JP
Biochem Biophys Res Commun; 1985 May; 129(1):117-25. PubMed ID: 2988544
[TBL] [Abstract][Full Text] [Related]
28. [Tuftsin].
Mücke D
Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
[TBL] [Abstract][Full Text] [Related]
29. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
[TBL] [Abstract][Full Text] [Related]
30. Anti-writhing activity of some peptides related to neurotensin and tuftsin.
Nicolaides ED; Lunney EA; Kaltenbronn JS; Wiley JN; Downs DA
Int J Pept Protein Res; 1985 Apr; 25(4):435-41. PubMed ID: 4019027
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of endogenous xenotropic murine retrovirus by treatment with the tetrapeptides, tuftsin and kentsin.
Suk WA; Long CW
J Gen Virol; 1981 Jan; 52(Pt 1):189-94. PubMed ID: 6167663
[TBL] [Abstract][Full Text] [Related]
32. The phagocytosis stimulating peptide tuftsin: further look into structure-function relationships.
Stabinsky Y; Gottlieb P; Fridkin M
Mol Cell Biochem; 1980 May; 30(3):165-70. PubMed ID: 6893216
[TBL] [Abstract][Full Text] [Related]
33. ADP-ribosylation of tuftsin suppresses its receptor-binding capacity and phagocytosis-stimulating activity to murine peritoneal macrophages.
Terashima M; Hara N; Badruzzaman M; Shimoyama M; Tsuchiya M
FEBS Lett; 1997 Jul; 412(1):227-32. PubMed ID: 9257725
[TBL] [Abstract][Full Text] [Related]
34. [Effect of tafcin on the functional activity and intracellular pH of mouse peritoneal macrophages].
Turovetskiĭ VB; Zolotilin SA; Sarycheva NIu; Kalikhevich VN; Kamenskiĭ AA
Biull Eksp Biol Med; 1994 Mar; 117(3):265-7. PubMed ID: 8204846
[No Abstract] [Full Text] [Related]
35. [Action of proteolytic enzymes from the cytosol of human erythrocytes on tuftsin, the peptide activator of phagocytosis].
Alekseenko LP; Orekhovich VN
Dokl Akad Nauk SSSR; 1984; 279(1):226-9. PubMed ID: 6518988
[No Abstract] [Full Text] [Related]
36. Tuftsin-like activity of amino acids.
Slopek S; Steuden W; Kaczmarek M
Arch Immunol Ther Exp (Warsz); 1983; 31(6):915-7. PubMed ID: 6678146
[TBL] [Abstract][Full Text] [Related]
37. Does tuftsin alter phagocytosis by human polymorphonuclear neutrophils?
Cooper MR; DeChatelet LR; Shirley PS; Cooper MR
Inflammation; 1982 Mar; 6(1):103-12. PubMed ID: 6896319
[TBL] [Abstract][Full Text] [Related]
38. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
Nishioka K; Amoscato AA; Babcock GF; Banks RA; Phillips JH
Cancer Invest; 1984; 2(1):39-49. PubMed ID: 6322938
[No Abstract] [Full Text] [Related]
39. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
40. Studies of human granulocyte phagocytosis stimulation by tuftsin.
Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
